MetLife (NYSE:MET – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Thursday.
Other research analysts have also issued reports about the company. Barclays began coverage on MetLife in a research report on Wednesday, September 4th. They set an “overweight” rating and a $91.00 price target on the stock. Jefferies Financial Group upped their price target on MetLife from $83.00 to $86.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. Citigroup upped their price target on MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a research report on Tuesday, July 23rd. Morgan Stanley dropped their price target on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. Finally, JPMorgan Chase & Co. upped their price target on MetLife from $81.00 to $86.00 and gave the company an “overweight” rating in a research report on Tuesday, July 2nd. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, MetLife currently has a consensus rating of “Moderate Buy” and an average target price of $85.23.
Get Our Latest Stock Report on MET
MetLife Trading Up 1.2 %
MetLife (NYSE:MET – Get Free Report) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $2.28 EPS for the quarter, beating the consensus estimate of $2.13 by $0.15. MetLife had a return on equity of 21.41% and a net margin of 4.23%. The business had revenue of $17.82 billion during the quarter, compared to the consensus estimate of $18.57 billion. During the same period in the prior year, the business posted $1.94 earnings per share. MetLife’s revenue was up 7.2% compared to the same quarter last year. Sell-side analysts predict that MetLife will post 8.68 EPS for the current year.
Institutional Trading of MetLife
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MET. GoalVest Advisory LLC grew its holdings in MetLife by 73.3% in the 1st quarter. GoalVest Advisory LLC now owns 390 shares of the financial services provider’s stock valued at $29,000 after buying an additional 165 shares during the last quarter. Pineridge Advisors LLC acquired a new stake in shares of MetLife during the 4th quarter worth approximately $39,000. Bank & Trust Co acquired a new stake in shares of MetLife during the 2nd quarter worth approximately $39,000. Crewe Advisors LLC grew its holdings in shares of MetLife by 602.5% during the 2nd quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 482 shares in the last quarter. Finally, Larson Financial Group LLC grew its holdings in shares of MetLife by 72.6% during the 2nd quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 239 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- What is the Hang Seng index?
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.